Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2009
10/13/2009CA2414665C Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
10/13/2009CA2386974C Benzodiazepine derivatives for use in acute or chronic neurological disorders
10/13/2009CA2341678C Potassium channel inhibitors and method
10/13/2009CA2291218C Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels
10/08/2009WO2009124167A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009124166A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009123948A2 Compounds and compositions as itpkb inhibitors
10/08/2009WO2009123870A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009WO2009123569A1 Method for treating neurological disorders with imidazolium and imidazolinium compounds
10/08/2009WO2009123221A1 Pyrimidine derivative having cell-protecting activity and use thereof
10/08/2009WO2009123194A1 Heterocyclic compound
10/08/2009WO2009123080A1 Indolinone compound
10/08/2009WO2009122430A2 Novel crystalline forms of desloratadine and process for preparing the same
10/08/2009WO2009122421A2 Improved process for eprosartan intermediate
10/08/2009WO2009122180A1 Pyrimidine derivatives capable of inhibiting one or more kinases
10/08/2009WO2009122034A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009WO2009121872A2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/08/2009WO2009121741A1 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
10/08/2009WO2009121740A1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
10/08/2009WO2009121288A1 A preparation method of phenylcarboxamides
10/08/2009WO2009080138A3 THE USE OF THE SPIN CROSSOVER COMPLEX [Mx+(L2)Hw]AN)z AS A MAGNETIC RESONANCE IMAGING CONTRAST AGENT
10/08/2009WO2009077874A3 A pharmaceutical composition for treating esophageal cancer
10/08/2009WO2008112022A8 4-piperidinylurea compounds as soluble epoxide hydrolase inhibitors
10/08/2009US20090253950 Radioactive member and method of making
10/08/2009US20090253911 New Compounds Useful for the Synthesis of S- and R-Omeprazole and a Process for Their Preparation
10/08/2009US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists
10/08/2009US20090253907 Cyclopentadienyl, indenyl or fluorenyl substituted phosphine compounds and their use in catalytic reactions
10/08/2009US20090253906 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
10/08/2009US20090253747 Remedy for sleep disturbance
10/08/2009US20090253745 Modulators of ocular oxidative stress
10/08/2009US20090253741 Alkene piperidine derivatives as antiviral agents
10/08/2009US20090253740 Substituted n-bicyclicalkyl bicycliccarboxyamide compounds
10/08/2009US20090253727 Nociceptin analogs
10/08/2009US20090253710 NMDA Receptor Antagonists for Neuroprotection
10/08/2009US20090253709 Synthesis, telomerase inhibition and cytotoxic studies on 2,7-disubstituted anthraquinone derivatives
10/08/2009US20090253708 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides
10/08/2009US20090253705 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009US20090253697 Novel Indole Derivatives, Preparation Thereof as Medicinal Products and Pharmaceutical Compositions, and Especially as KDR Inhibitors
10/08/2009US20090253694 Fused hetrocyclic compounds
10/08/2009US20090253691 Trisubstituted 1,2,4-triazoles
10/08/2009US20090253690 N-[3-(1-piperidinyl)propoxy]-pyridin-1-oxide-3-carboxamidine; cardiovascular disorders; treating dysfunction of endothelial cells
10/08/2009US20090253688 Semicarbazide derivatives as kinase inhibitors
10/08/2009US20090253684 Leukotriene b4 inhibitors
10/08/2009US20090253682 Heterocyclic derivatives for modulation of calcium channels
10/08/2009US20090253679 New imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular cdc7
10/08/2009US20090253674 Substituted Triazole Derivatives As Oxytocin Antagonists
10/08/2009US20090253673 Substituted Pyrazoles as Ghrelin Receptor Antagonists
10/08/2009US20090253655 Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
10/08/2009CA2720490A1 Compounds and compositions as itpkb inhibitors
10/08/2009CA2720275A1 Indolinone compound
10/08/2009CA2720049A1 Pyrimidine derivative having cell protecting effect and uses thereof
10/08/2009CA2720004A1 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
10/08/2009CA2719907A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009CA2719876A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/08/2009CA2718645A1 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as hdl-cholesterol raising agents
10/08/2009CA2718488A1 Novel dhsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
10/08/2009CA2717537A1 2-trifluoromethylnicotinamide derivatives as hdl-cholesterol raising agents
10/07/2009EP2106398A2 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd)
10/07/2009EP2106397A1 A process for preparation of enantiomerically pure esomeprazole
10/07/2009EP2106396A2 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
10/07/2009EP2106213A2 Substituted 1-(3-pyridinyl)pyrazole-4-yl acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
10/07/2009EP1756087B1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
10/07/2009EP1663985B1 Pesticides
10/07/2009EP1309566B1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
10/07/2009EP1308441B1 2-aminopyridine compounds and use thereof as drugs
10/07/2009CN101553483A 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
10/07/2009CN101553482A Kinase inhibitor compounds
10/07/2009CN101553481A Substituted sulfonamide derivatives
10/07/2009CN101553480A Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
10/07/2009CN101553471A 抗菌喹啉衍生物 Antibacterial quinoline derivatives
10/07/2009CN101553470A Antibacterial quinoline derivatives
10/07/2009CN101553468A Organic compounds
10/07/2009CN101553460A Process for preparing 2-amino-5-cyanobenzoic acid derivatives
10/07/2009CN101553256A Phenylpropionamide compounds and the use thereof
10/07/2009CN101550132A Arylvinylazacycloalkane compounds and methods of preparation and use thereof
10/07/2009CN101550131A Alpha crystal form of ketanserin and method for preparing the same
10/07/2009CN101550130A Method for preparing 3-halo-1-(3-chloro -2-pyridyl)-1H-pyrazole-5-formyl halide
10/07/2009CN101550104A Benzene-naphthalene diimide derivative, preparation method and its application
10/07/2009CN101550103A 1, 2, 3, 4-tetrahydroisoquinoline derivatives and synthetic method and uses thereof
10/07/2009CN101548974A Compound having fluorescent characteristic and anti-cancer activity, preparation thereof and application thereof
10/06/2009US7598423 e.g. 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist;
10/06/2009US7598396 Contacting carvedilol and ethyl acetate to form a solution, and cooling the solution whereby a precipitate is formed; improves performance characteristics of pharmaceutical product
10/06/2009US7598394 Made by reacting a cyano compound with a silylalkylisocyanide compound; silylimidazole ;
10/06/2009US7598384 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders
10/06/2009US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
10/06/2009US7598379 Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines
10/06/2009US7598377 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy
10/06/2009US7598360 Bisstyryl compound and high density recording media utilizing the same
10/06/2009US7598359 High density recording media with modified recording layers of the invention provides better photoelectrical performance; high recording sensitivity and high carrier-to-noise ratio
10/06/2009US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
10/06/2009US7598284 Indazole compounds as B3 adrenoceptor agonist
10/06/2009US7598279 Neurotherapeutic azole compounds
10/06/2009US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine
10/06/2009US7598274 Pyrrole derivatives
10/06/2009US7598273 Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties
10/06/2009US7598272 Kinase inhibitors
10/06/2009US7598270 Diagnostic agent for detecting colorectal carcinoma by detecting presence of HERG potassium channel in tissue biopsy of human colon or rectum or in lymph nodes, which are free of HERG potassium channels in healthy human; 4-[1-[2-(6-methyl-2-pyridinyl)ethyl-4-piperidin-yl]carbonyl]methanesulfoanilide
10/06/2009US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents
10/06/2009US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
10/06/2009US7598255 Pyrimidine compounds as serotonin receptor modulators
1 ... 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 ... 1080